The Case: A previously healthy 24-year-old man presented to the emergency department with sudden onset of severe periumbilical and right costovertebral pain accompanied by nausea and vomiting. His ...

The practice of medical genetics has evolved from focusing on rare, single-gene disorders to including more prevalent, multigenic disorders. The geneticist may be called upon to participate in the ...

December 21, 2007 -- The US Food and Drug Administration (FDA) has granted orphan drug designation to CDX-110 for the treatment of glioblastoma multiforme, ATryn for the treatment of hereditary ...

Thrombate III is the only antithrombin concentrate approved in both adult and pediatric patients for hereditary antithrombin deficiency. The Food and Drug Administration (FDA) has expanded the ...

BOSTON, Mass., July 16, 2009– Data presented at the annual meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Boston show that ATryn® (Antithrombin [Recombinant]) safely ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark (LUN: Copenhagen Stock Exchange), announced today that ATryn ® (Antithrombin [Recombinant]) is ...

When to treat patients with heparin and when to treat using an antithrombin concentrate; Why it is important to aggressively treat patients with type one antithrombin deficiency who have already ...

INNOVANCE Antithrombin assay is a cutting-edge, ready-to-use chromogenic reagent for the automated determination of antithrombin (AT) activity. It is highly accurate even at low activity levels and ...

SEATTLE, April 09, 2021, (PHARMIWEB) — Antithrombin is a protein present in blood that inactivates thrombin to restrict blood clotting. The protein in produced by liver and contains 432 amino acids.